• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    UK Celiac Disease Treatment Market

    ID: MRFR/HC/49597-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    UK Celiac Disease Treatment Market Research Report By Treatment Type (Gluten Free Diet, Vitamin and Minerals Supplements, Medical Therapies) and By End User (Hospitals and Clinics, Research Centers, Others)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    UK Celiac Disease Treatment Market Research Report- Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    UK Celiac Disease Treatment Market Summary

    The United Kingdom Celiac Disease Treatment market is projected to experience substantial growth over the next decade.

    Key Market Trends & Highlights

    UK Celiac Disease Treatment Key Trends and Highlights

    • The market valuation is expected to rise from 40.3 USD Million in 2024 to 136.1 USD Million by 2035.
    • A compound annual growth rate (CAGR) of 11.71 percent is anticipated from 2025 to 2035.
    • This growth trajectory indicates a robust demand for effective treatment options in the UK.
    • Growing adoption of gluten-free diets due to increased awareness of celiac disease is a major market driver.

    Market Size & Forecast

    2024 Market Size 40.3 (USD Million)
    2035 Market Size 136.1 (USD Million)
    CAGR (2025-2035) 11.71%

    Major Players

    Schär, Free2b, Gluten Free Foods, Alpro, LiveGfree, Baker & Baker, Kind Snacks, Natasha's Law, Schar UK Ltd, Doves Farm, Genius Gluten Free, Against the Grain, BFree Foods, Dr. Schär, Orgran

    UK Celiac Disease Treatment Market Trends

    The UK Celiac Disease Treatment Market is experiencing notable trends driven by increasing awareness and understanding of celiac disease among the general population and healthcare professionals. The National Health Service (NHS) has been actively promoting better diagnosis and management strategies for this condition, which is encouraging more people to seek treatment options. This rise in diagnosis has sparked greater demand for gluten-free products and treatments, creating a dynamic market environment. 

    Opportunities in the UK market include the expansion of gluten-free food products in mainstream grocery stores and online platforms. With the growing inclination toward healthier eating habits, brands are recognizing the potential to cater to celiac patients while also appealing to a broader audience looking for gluten-free options.The release of new and gluten-free products is shifting the focus of manufacturers as they attempt to capture the attention of health-driven consumers. 

    There has been a recent change in the way celiac disease is approached, as it now favors personalized treatment. The technology used to manage the illness is also improving, as tools for gluten tracking and professional consultation services are now available online. Alongside these changes, there is an increase in the use of dietary and other treatment supplements, which can improve the patient experience.

    This trend also reflects a broader movement toward holistic health within the UK, where health products and therapies that embrace a whole-person approach are becoming increasingly popular among consumers. Overall, the UK Celiac Disease Treatment Market is poised for significant growth, driven by greater awareness, opportunities for innovation, and trends towards more personalized healthcare solutions.

    Market Segment Insights

    UK Celiac Disease Treatment Market Segment Insights

    UK Celiac Disease Treatment Market Segment Insights

    Celiac Disease Treatment Market Treatment Type Insights

    Celiac Disease Treatment Market Treatment Type Insights

    The UK Celiac Disease Treatment Market, particularly focused on the Treatment Type segment, showcases a diverse offering designed to meet the varying needs of individuals diagnosed with celiac disease. A principal element within this segment is the Gluten Free Diet, a fundamental and essential treatment method that is widely recognized as the cornerstone for managing celiac disease. 

    This dietary approach involves the complete avoidance of foods containing gluten, a protein found in wheat, barley, and rye, which can cause serious health issues for individuals with this condition. As awareness regarding gluten intolerance and celiac disease continues to grow across the UK, the prevalence of gluten-free food products is on the rise, resulting in increased availability and variety within supermarkets and health stores. Moreover, the trend towards organic and clean-label products has fostered an environment where gluten-free options are not only more accessible but also more appealing to consumers, leading to a sizable market share for this diet.

    Complementing the dietary approach are Vitamin and Minerals Supplements, an important support mechanism for individuals with celiac disease. Due to the malabsorption issues often faced by these patients, leading to nutrient deficiencies, these supplements play a crucial role in improving overall health and quality of life. The growing recognition of the role of nutrition in managing celiac disease symptoms has led to an increased interest in fortified supplements, driving market demand. 

    Health professionals often recommend such supplements to patients on gluten-free diets, ensuring they meet their nutritional requirements, further solidifying the significance of this treatment type within the UK Celiac Disease Treatment Market.Medical Therapies also represent another vital component of the Treatment Type segment. While the primary treatment for celiac disease remains a strict gluten-free diet, there is ongoing Research and Development aimed at providing additional therapeutic options for patients who struggle with dietary compliance or who experience persistent symptoms despite adhering to a gluten-free regimen. 

    Celiac Disease Treatment Market End User Insights

    Celiac Disease Treatment Market End User Insights

    The UK Celiac Disease Treatment Market showcases a diverse range of End Users, with significant contributions from Hospitals and Clinics, Research Centers, and other platforms. Hospitals and Clinics play a pivotal role as primary healthcare providers, offering diagnostic services and treatment plans that adhere to clinical guidelines. Their significance is underlined by the growing prevalence of celiac disease in the UK, which necessitates immediate medical attention and management. 

    Research Centers further enhance the market dynamics by focusing on innovative treatments and therapies, contributing to enhanced patient care and understanding of the disease.This segment fosters advancements in Research and Development, leading to improved diagnostic tools and therapeutic options. Additionally, other players in the segment, such as dietary services and health education platforms, bridge the gap between medical treatment and lifestyle adjustments, promoting better health outcomes. 

    The growing awareness and recognition of celiac disease in the UK, coupled with emerging treatment methodologies, create a robust landscape for the End User segment, ultimately driving market growth and improving patient quality of life.Overall, the segmentation reflects a comprehensive approach to addressing the needs of celiac disease patients, aligning with trends towards personalized medicine and patient-centered care in the healthcare industry.

    Get more detailed insights about UK Celiac Disease Treatment Market Research Report- Forecast to 2035

    Key Players and Competitive Insights

    The UK Celiac Disease Treatment Market has witnessed significant growth in recent years, driven by an increasing awareness of celiac disease among the population and a rising demand for gluten-free products. As more individuals are diagnosed with this autoimmune disorder, the market has seen an inflow of various players offering gluten-free alternatives and specialty treatments aimed at improving the quality of life for those affected. 

    The competitive landscape is defined by the collaboration of pharmaceutical companies, nutritional brands, and food manufacturers, all focused on developing innovative solutions that cater specifically to the needs of celiac patients. Companies operate in a challenging environment where regulatory standards and consumer preferences rapidly evolve, making adaptability and market intelligence crucial for success.

    Schär is a prominent player in the UK Celiac Disease Treatment Market, known for its extensive range of gluten-free products that cater specifically to those managing celiac disease. The company's strengths lie in its robust product portfolio, which includes everything from baked goods to pasta alternatives, providing consumers with versatile options to meet their dietary needs. Schär's established presence in the UK market is bolstered by its commitment to research and development, ensuring that its offerings not only meet state-of-the-art gluten-free standards but are also appealing to a broader audience, including those without dietary restrictions. 

    The brand has successfully positioned itself as a go-to choice for celiac patients, cultivating a loyal customer base through consistent quality and targeted marketing strategies.Free2b operates within the UK Celiac Disease Treatment Market as a brand dedicated to providing safe, nutritious options for those requiring gluten-free foods. The company's key offerings include a range of snacks and meal solutions designed for individuals managing celiac disease. Free2b prides itself on utilizing high-quality ingredients and ensuring that all products are free from gluten and other allergens, thereby enhancing its appeal in the competitive landscape. 

    The brand's market presence has been further reinforced through strategic partnerships and collaborations aimed at expanding its distribution channels within the UK. By focusing on consumer needs and preferences, Free2b has carved out a niche in the market that underscores its strengths in innovation and customer engagement. The company has also explored potential mergers and acquisitions to broaden its reach and enhance its product offerings, positioning itself as a relevant player in the constantly evolving gluten-free sector.

    Key Companies in the UK Celiac Disease Treatment Market market include

    Industry Developments

    In recent developments within the UK Celiac Disease Treatment Market, companies like Schär and Genius Gluten Free have continued to innovate their product lines, enhancing availability for consumers with gluten sensitivity. The introduction of new gluten-free options from brands such as Alpro and Doves Farm has broadened the market landscape, catering to the increasing demand for better dietary choices. 

    Notably, in August 2023, Schar UK Ltd announced a partnership with local supermarkets to improve product access, while Free2b unveiled new snack lines targeting health-conscious consumers. The market's valuation has benefited from a growing awareness of celiac disease, with a reported increase in sales across gluten-free products by over 15% in 2022. In terms of mergers and acquisitions, no major developments have been reported for Schär, Free2b, or other relevant companies in the last few months. 

    However, pre-2022, several collaborations were noted, emphasizing a trend towards consolidation and sharing of resources within the industry. This environment indicates a robust growth trajectory for the UK market, fostering increased investment and development, while the introduction of Natasha's Law is expected to further enhance consumer confidence in gluten-free labeling and safety.

    Market Segmentation

    Celiac Disease Treatment Market End User Outlook

    • Hospitals and Clinics
    • Research Centers
    • Others

    Celiac Disease Treatment Market Treatment Type Outlook

    • Gluten Free Diet
    • Vitamin and Minerals Supplements
    • Medical Therapies

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 36.26(USD Million)
    MARKET SIZE 2024 40.26(USD Million)
    MARKET SIZE 2035 136.1(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 11.709% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Schär, Free2b, Gluten Free Foods, Alpro, LiveGfree, Baker & Baker, Kind Snacks, Natasha's Law, Schar UK Ltd, Doves Farm, Genius Gluten Free, Against the Grain, BFree Foods, Dr. Schär, Orgran
    SEGMENTS COVERED Treatment Type, End User
    KEY MARKET OPPORTUNITIES Expanded gluten-free product offerings, Digital health solutions development, Improved diagnostic testing methods, Increased awareness and education campaigns, Personalized treatment options and therapies
    KEY MARKET DYNAMICS rising diagnosis rates, increasing healthcare awareness, growing gluten-free product demand, advancements in treatment options, supportive government regulations
    COUNTRIES COVERED UK

    FAQs

    What is the expected market size of the UK Celiac Disease Treatment Market in 2024?

    The UK Celiac Disease Treatment Market is expected to be valued at 40.26 USD Million in 2024.

    What is the projected market size for the UK Celiac Disease Treatment Market by 2035?

    By 2035, the market is projected to be valued at 136.1 USD Million.

    What is the expected compound annual growth rate (CAGR) for the UK Celiac Disease Treatment Market from 2025 to 2035?

    The UK Celiac Disease Treatment Market is expected to grow at a CAGR of 11.709% from 2025 to 2035.

    Which treatment type is the largest segment in the UK Celiac Disease Treatment Market in 2024?

    The Gluten Free Diet segment is the largest, valued at 17.1 USD Million in 2024.

    What is the expected growth for the Vitamin and Minerals Supplements segment by 2035?

    The Vitamin and Minerals Supplements segment is expected to grow to 43.8 USD Million by 2035.

    Who are the key players in the UK Celiac Disease Treatment Market?

    Key players include Schär, Free2b, Alpro, Baker & Baker, and Genius Gluten Free among others.

    What is the market value for Medical Therapies in the UK Celiac Disease Treatment Market in 2024?

    The Medical Therapies segment is valued at 10.36 USD Million in 2024.

    What is the expected market value for the Gluten Free Diet segment in 2035?

    The Gluten Free Diet segment is expected to reach 58.6 USD Million in 2035.

    What are the growth drivers for the UK Celiac Disease Treatment Market?

    Drivers include increasing awareness about celiac disease and the growing demand for gluten-free products.

    How does the UK Celiac Disease Treatment Market compare regionally?

    The UK represents a significant share of the global market, driven by rising diagnoses of celiac disease.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials